SUMMARY We performed electroretinogr-ams (ERG) on both eyes of 11 diabetic patients before and one month after panretinal photocoagulation for diabetic retinopathy. Each patient had one eye treated with argon laser and the fellow eye treated with the xenon arc photocoagulator. After photocoagulation the ERG was symmetrically reduced unless the retinal area burned with xenon arc was greater than twice the retinal area burned in the fellow eye by the argon laser photocoagulator.
Panretinal photocoagulation (PRP) has been shown to reduce the risk of blindness caused by moderate to advanced proliferative diabetic retinopathy. ' The amount of retinal destruction following PRP may determine the effectiveness of the treatment. We used electroretinograms (ERGs) following argon laser and xenon arc panretinal photocoagulation to evaluate the amount of functional retina destroyed.
Materials and methods
Eight men and 3 women with bilateral symmetrical severe nonproliferative diabetic retinopathy (DRS group 3)1 or proliferative diabetic retinopathy without vitreous contraction (DRS groups 4-6)' were selected. All were white and their ages ranged from 19 to 60 years with a mean of 43-5 years.
Each patient had a complete ophthalmic examination including best corrected visual acuity, slit-lamp examination, intraocular pressure measurement, and dilated direct and indirect ophthalmoscopy. Fundus photographs and fluorescein angiography were also obtained. Their retinopathy was classified by the modified Airlie House classification.
Each patient received panretinal photocoagulation (PRP) in one eye with an argon laser and in the fellow eye with a xenon arc photocoagulator. treatment were randomly assigned for each eye. The PRP treatments were carried out in one to 3 sessions at least 2 weeks apart. The treatment technique has been previously described. 2 The treatment parameters are summarised in Table 1 . Electroretinograms were performed in both eyes before and one month after treatment of the second eye by a modification of a procedure previously described.3 Specifically, photopic a and b wave amplitudes and implicit times were determined as well as 20 minute scotopic a and b wave amplitudes and implicit times using a white light with the I,6 setting on a Grass PS-2 photostimulator. The normal intertesting variability in our laboratory is between 5 and 15% for the ERG amplitudes and is 2 milliseconds for the ERG implicit times. 
Results
The retinal area and percentage of the total retinal area burned was consistently greater (p=0-000012) with xenon arc PRP than with argon laser PRP ( Table  2 ). The individual panretinal photocoagulation data are presented in Table 3 .
The pre-and post-treatment ERG photopic and scotopic responses are presented in Tables 4 and 5,   respectively; the ERG response changes and  percentage changes are presented in Tables 6 and 7 Normal amplitude variability is 5-15% for our laboratory. Normal implicit time variability is 2 ms for our laboratory. Ogden and associates' performed argon laser or xenon arc PRP on 14 eyes. They measured a decrease in ERG amplitude that varied from 10 to 95% among the patients and also an increase in ERG latency and implicit time in several patients. They suggested that there was a wide variability in the area of retina affected by the treatment, although they did not calculate the area of retina treated. They also suggested the possibility of the PRP affecting adjacent untreated retina in some diabetic patients.
Schuurmans and associates6 performed intense xenon arc PRP in 5 rabbits, treating either the nasal retina, the posterior pole, or the entire retina, after which the ERG response was compared with the histologically measured area of retinal damage. They concluded that, when less than 30% of the retina is treated, the ERG is reduced proportionally to the retinal area destroyed; when greater than 30% of the retinal surface is destroyed, the decrease in response is greater than the enlargement of the coagulated area-that is, they found that 60% retinal destruction decreased the ERG 80%. Our results indicate that the ERG is of some use in measuring the effect of PRP treatment. However, the effect on the ERG by the area of retina coagulated can be correlated only in a moderate sense. This lack of a close correlation is a reflection of the variability of the health of different areas of the diabetic retina and also of the treatment technique. However, it is useful to know the comparative effect on the ERG for 2 types of treatment as they are commonly performed today.
The typical xenon PRP burns roughly twice the area of the typical argon PRP. This is a reasonable explanation for the greater peripheral field loss in xenon treated eyes as compared with argon treated eyes. 8 It might be possible to reduce the side effects of xenon PRP while maintaining its beneficial effects by reducing the area of retina burned to correspond to a typical argon PRP. 
